Clinical Operations in Oncology Trials Europe 2019
27-28 November 2019, Zurich, Switzerland
Rising Above Local Competition Through Optimisation of Operationally Efficient, Specifically Targeted Oncology Clinical Trials
As the only operationally focussed oncology conference in Europe this two-day event is a must attend. The 2019 Clinical Operations in Oncology Trials Europe Conference will be moving to Zurich for its 6th edition, with more interactive content and senior level speakers than before.
The 2019 programme will host speakers from the likes of Novartis Oncology, Bristol-Myers Squibb, Novocure, Janssen and The Swedish Medicines Agency.
Sessions you wont want to miss from this years’ agenda include a Live Debate on whether patient recruitment is best at the grass roots level vs on social media; an interactive panel discussion on how best to put patients in the centre of your trial; and a brand new ‘Technology & Innovation’ section on the afternoon of Day 1 discussing hot topics like AI and digital healthcare.
This conference provides a networking platform to discuss key issues with your fellows, facilitating the formation of new partnerships and strengthening existing relationships.
CTO Europe will be held in Zurich on 27th & 28th November 2019. Please get in touch if you are interested in taking part!
WHAT TO EXPECT FOR 2019
At the Clinical Operations in Oncology Trials Europe event, taking place on the 27th November in Zurich, we are pleased to bring together the definitive group of executives responsible for clinical operations in oncology and enhancing the partnership with vendors. There will be expert guidance through a first class conference programme and numerous networking opportunities.
ATTENDEES TO MEET EACH YEAR
EXHIBITORS TO MEET EACH YEAR
ATTENDEES AT DIRECTOR + LEVEL
This is an exceptional networking opportunity for industry accelerators. Meet industry C-Suite and Director level executives to make valuable connection at this annual thought leadership platform.
Join like-minded peers to learn new perspectives and case studies through presentation, panel discussions, interactive round tables and workshops.
The conference discusses the vital connections between process, tools and techniques to manage change. Update your knowledge to create new strategies enabling you to enact change.
ACT Oncology is now Precision Oncology, part of Precision for Medicine. We are the first Precision Medicine Research Organization dedicated to oncology research. We offer sponsors integrated oncology clinical trial and biomarker services - all under one roof. With our own Oncology Site Network dedicated to 90-day start up, biomarker and analytics services and expert clinical trial execution, we provide sponsors with an accelerated pathway to proof-of- concept and all the way through registration for their oncology innovations.
Linical is a global speciality CRO headquartered in Osaka, Japan, listed in the prime segment of the Tokyo Stock exchange, and dedicated to serve its clients as a true partner in development. With more than 900 employees Linical directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe and N. America via its own offices.
Metronomia is a German clinical research organization (CRO) committed to high quality, best service and outstanding flexibility. A service oriented, stable and highly skilled team provides e-clinical services,clinicaldata management and biostatistical services within phase I – IV and non-interventional studies in allmajor therapeutic areas.